Rituximab
RITULUP
Phase 3 mab terminated
Quick answer
Rituximab for Lupus Nephritis is a Phase 3 program (mab) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Lupus Nephritis
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated